Outsourced Pharma App Notes & Case Studies
-
Characterization Of Host Cell Proteins By Liquid Chromatography - Mass Spectrometry
2/26/2024
Explore an established liquid chromatography – tandem mass spectrometry (LC-MS/MS) method for characterization of residual HCPs in monoclonal antibody (mAb) products.
-
Streamlining The Integrity Testing Process – From Test To Report
2/22/2023
Discover a digital transformation solution that provides first of its kind data analytics for filter integrity testing. The software helps operators and supervisors reduce time lost through review processes.
-
Biacore™ SPR Systems For Titer Analysis Of Adeno-Associated Virus
10/13/2022
We describe the performance of two assays for titer analysis of adeno-associated virus (AAV), serotype 2 and serotype 5, based on surface plasmon resonance (SPR).
-
Lipid Nanoparticle Compositional Analysis By UHPLC-CAD
6/30/2023
Explore results generated from an internal study using a proprietary mRNA-LNP formulation and UHPLC-CAD, a powerful technique for the analysis of compounds that do not contain chromophores.
-
Apheresis Variability Control In Cell Therapy Manufacturing
7/25/2022
Explore our best practices for apheresis collection and obtention of enriched product for cell therapies.
-
Peptide Mapping Of AAV By LC-MS
9/29/2022
View the results generated from an internal study where peptide mapping of two different AAV serotypes – AAV8 and AAV9 – was performed by LC-MS.
-
Recombinant Protein Purification Optimization With HIC
5/1/2023
A step-by-step high-throughput process development (HTPD) workflow to determine the optimal resin and initial conditions for hydrophobic interaction chromatography (HIC).
-
Engineering Approaches To Respiratory Drug Delivery
5/27/2022
Explore the material and performance properties of spray-dried and jet-milled mannitol for respiratory delivery of crystalline mannitol.
-
Secondary Packaging Strategies For Commercial Launch Of A Biologic
8/17/2022
A commercial packaging solution can be the first and enduring impression that a sponsor company makes on a patient, and its suitability can impact a biologic’s commercial success.
-
Capture Of Bispecific Antibodies And Removal Of Product-Related Impurities
11/17/2022
Many antibody variants are prone to aggregation or to forming product-related impurities. Explore the application of a resin with novel selectivity to purify challenging entities.